Bridgeworth’s CVS Health CVS Stock Holding History

Bridgeworth’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-603	Closed	-$38K	–	216
2018 Q2	$38K	Buy	+603	New	+$39.7K	0.02%	315

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Bridgeworth's CVS Position: Q3 2018 in Review

Bridgeworth sold out of CVS Health (CVS) in Q3 2018, closing a stake of 603 shares — an estimated $38K sold.

Bridgeworth first reported a position in CVS in Q2 2018 and held it in 1 quarter. The position peaked at $38K in Q2 2018. 1,599 funds tracked by Wall St. Rank hold CVS as of Q3 2018.

Bridgeworth reported no remaining CVS Health position as of Q3 2018 after selling out during the quarter.
Bridgeworth sold 603 CVS Health shares in Q3 2018, an estimated $38K.
Bridgeworth first reported a position in CVS Health in Q2 2018 and held it in 1 quarter.
Bridgeworth's CVS Health position peaked at $38K in Q2 2018.
1,599 funds tracked by Wall St. Rank held CVS Health as of Q3 2018.

Based on Bridgeworth's 13F filing for Q3 2018, filed 13 Nov 2018.